Outlook Therapeutics, Inc.
through May 7, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | Jan 27, 2025 · D | May 7, 2026 · D | Later minus earlier |
|---|---|---|---|
| Reported offering amount | $31,977,359 | $5,000,000 | $-26,977,359 |
| Reported amount sold | $0 | $0 | $0 |
| Reported investor count | — | — | — |
| Reported minimum investment | $0 | $0 | $0 |
Earlier SEC source: 0001231919-25-000018 · Later SEC source: 0001231919-26-000465
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot
- Reported offering amount
- $5,000,000
- Reported amount sold
- $0
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Filings by year
- 20251 filing
- 20261 filing
Submission counts, including amendments; not dollars raised or distinct funding rounds.
Contact info
Log in to look up an email or website for this issuer.
Form D filings (2)
-
0001231919-26-000465D · May 7, 2026 · BiotechnologyOffering: $5,000,000Sold: $0
-
0001231919-25-000018D · Jan 27, 2025 · BiotechnologyOffering: $31,977,359Sold: $0